Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years - Aix-Marseille Université Access content directly
Journal Articles Clinical Cancer Research Year : 2020

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Ali Bazarbachi
Christoph Schmid
Myriam Labopin
Dietrich Beelen
  • Function : Author
Igor Wolfgang Blau
  • Function : Author
Victoria Potter
  • Function : Author
Riitta Niittyvuopio
  • Function : Author
Gerard Socié
Jaime Sanz
Fabio Ciceri
Iman Abou Dalle
  • Function : Author
Alexandros Spyridonidis
Gesine Bug
  • Function : Author
Jordi Esteve
Bipin Savani
Arnon Nagler
Mohamad Mohty

Domains

Immunology

Dates and versions

hal-03152852 , version 1 (25-02-2021)

Identifiers

Cite

Ali Bazarbachi, Christoph Schmid, Myriam Labopin, Dietrich Beelen, Igor Wolfgang Blau, et al.. Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years. Clinical Cancer Research, 2020, 26 (24), pp.6475-6482. ⟨10.1158/1078-0432.CCR-20-3134⟩. ⟨hal-03152852⟩

Collections

CNRS UNIV-AMU CRCM
21 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More